Sun Pharmaceutical Industries, in March 2015, announced to acquire the opiates business of British drug maker GlaxoSmithKline (GSK) in Australia, in keeping with a strategy to venture into areas where competition is limited. The poppy-derived opiate raw material is mainly used to make painkillers